Showing 6421-6430 of 7281 results for "".
- Dermablend Launches Concealer and Highlighter for Clearer Complexionhttps://practicaldermatology.com/news/20130314-dermablend_launches_concealer_and_highlighter_for_clearer_complexion/2459590/Dermablend's new Quick-Fix Illuminator is a multi-purpose concealer and highlighter that can conceal, smooth, illuminate, brighten, highlight and sculpt the face for an improved complexion. According to the company, the Quick-Fix Illuminator is safe for even the most sensitive skin diminishes dark c
- Cynthia Nixon Partners with Galderma and the NRS to Raise Awareness for Rosaceahttps://practicaldermatology.com/news/20130314-cynthia_nixon_partners_with_galderma_and_the_nrs_to_raise_awareness_for_rosacea/2459591/Actress Cynthia Nixon recently joined with dermatologists Rick Fried, MD and Flor Mayoral, MD and a panel of other experts at the "Face to Face with Rosacea: Empowering Professionals and Patients" educational event at the AAD Meeting in Miami. Sponsored by Galderma in conjunction with the National R
- AMBI Skincare Announces Annual Skin of Color Society Research Awardhttps://practicaldermatology.com/news/20130312-ambi_skincare_announces_annual_skin_of_color_society_research_award/2459592/The annual AMBI Skin of Color Society Research Award was recently presented to Jenna O'Neill, MD, for her contribution to dermatological research in skin of color, specifically in characterizing the genetic basis of central centrifugal cicatricial alopecia. The Award is sponsored by a $15,000 grant
- Galderma Launches Online Epiduo Adherence Programhttps://practicaldermatology.com/news/20130312-galderma_launches_online_epiduo_adherence_program/2459593/Galderma announced its new Epiduo TAP (Treatment, Adherence, and Performance) Program, an online and mobile patient platform that educates acne patients ages 13 and older about the proper application of Epiduo (adapalene and benzoyl peroxide 0.1%/2.5%) Gel and encourages acne patients to stay adhere
- Investigational Injectable Found Safe, Effective for Submental Fathttps://practicaldermatology.com/news/20130311-investigational_injectable_found_safe_effective_for_submental_fat/2459596/An investigational injectable drug for the reduction of submental fat called ATX-101 from Kythera Biopharmaceuticals was found both safe and effective in new data presented at the AAD Meeting in Miami. In the open-label Phase IIIb study, interim results three months after the last ATX-101 treatment
- Apremilast Phase III Results Show Efficacy Over Time for Psoriasishttps://practicaldermatology.com/news/20130311-apremilast_phase_iii_results_show_efficacy_over_time_for_psoriasis/2459597/Results from a new Phase III study presented at the AAD Meeting in Miami demonstrate the efficacy of the oral molecule apremilast (Celgene) in psoriasis patients. The ESTEEM 1 study evaluated efficacy and safety in a range of patients, approximately one-third of which was systemic and/or phototherap
- Valeant Launches Acne Scholarship Programhttps://practicaldermatology.com/news/20130311-valeant_launches_acne_scholarship_program/2459598/Valeant Dermatology recently launched a scholarship program entitled, Acanya® I Can Succeed, an initiative that will provide college scholarship money to students who have had acne and have actively tried to address it. The Acanya I Can Succeed Scholarship program will award a total of up to $48,000
- AAD Unveils New App for Diagnosing and Treating Psoriasishttps://practicaldermatology.com/news/20130311-aad_unveils_new_app_for_diagnosing_and_treating_psoriasis/2459599/At its recent annual meeting in Miami, The American Academy of Dermatology introduced a mobile app of evidence-based clinical guidelines for diagnosing and treating psoriasis and psoriatic arthritis. The free app includes a clinical decision tree; reference guide for diagnoses; arthritic diagnostic
- PreCision Dermatology Appoints Chief Operating Officerhttps://practicaldermatology.com/news/20130307-precision_dermatology_appoints_chief_operating_officer/2459601/Robert Moccia has been appointed to the newly created position of Chief Operating Officer of PreCision Dermatology, Inc. In that role, all operating functions of PreCision will report to Mr. Moccia. In addition, Mr Moccia will serve as the President of Onset Dermatologics, LLC, a wholly owned subsid
- Novan Therapeutics Presents Data for Potential Topical Agent that Reduces Sebum in Acne Patientshttps://practicaldermatology.com/news/20130228-novan_therapeutics_presents_data_for_potential_topical_agent_that_reduces_sebum_in_acne_patients/2459602/Recent in vitro and animal testing data from Novan Therapeutics indicate that the company's drug candidate, SB204, could lead to a topical treatment for acne that reduces oil production in the skin. Dr. Diane Thiboutot, Professor of Dermatology at Penn State Hershey College of Medicine, notes that,